Misonix announced today that it has received the necessary Registration Certificate from the State Food and Drug Administration (SFDA) of the People's Republic of China (PRC) to market and sell its BoneScalpel (Ultrasonic Osteotome System) product in China.
The medical device industry is constantly changing. New technologies and products enter the market, replacing outdated or inefficient equipment. There are numerous benefits in using LEDs for medical illumination applications including longer life, less heat, dynamic control, lower energy consumption, and in many cases, lower cost.
Abbott has announced it has entered into an agreement to purchase OptiMedica Corporation, a privately held, Silicon Valley-based ophthalmic device company. The acquisition will enable Abbott to expand its vision care business into the femtosecond laser-assisted cataract surgery market.
The Federal Bureau of Investigation snagged $4 million in settlements with two clinics and a Michigan cardiologist accused of performing unnecessary cardiac surgeries. Federal investigators accused Dr. Jashu Patel and his Jackson Cardiology Associates practice as well as Allegiance Health of subjecting patients "to invasive and potentially harmful procedures" that led to at least one patient's death.
First experiencing symptoms at just 29-years-old and diagnosed with Parkinson's at age 34, Tommy Zuleger is the youngest patient ever treated at the Muhammad Ali Parkinson Center at Barrow Neurological Institute in Phoenix and he says a new "sci-fi" procedure has given him his life back.
Royal Philips and Georgia Regents Medical Center have announced a 15-year alliance to enable increasingly patient-centered approaches to care and to create an innovative business model that addresses current and future clinical, operational and equipment needs of GRMC’s multiple sites.
Researchers at the University of Southampton have completed a project that will enable surgeons to fit joint replacements with longer, optimised lifespans. The MXL project uses computational modelling to define the mechanics of an artificial joint to ensure successful surgery and longer lifespans of the prosthetic joints.
A new proposal from the Centers for Medicare & Medicaid Services would help level at least 1 battlefield between radiosurgery devices makers Elekta and Varian Medical Systems. The reimbursement proposal would offer equal payment to healthcare providers conducting single-treatment radiosurgery for brain tumors, whether the procedure is conducted with Elekta's Gamma Knife or Varian's Linac.
Half a millennium after Johannes Gutenberg printed the bible, researchers printed a 3D splint that saved the life of an infant born with severe tracheobronchomalacia, a birth defect that causes the airway to collapse. While similar surgeries have been preformed using tissue donations and windpipes created from stem cells, this is the first time 3D printing has been used to treat tracheobronchomalacia—at least in a human.
The trial of a personal injury lawsuit filed against C.R. Bard ended in mistrial today after a federal judge granted Bard's motion to dismiss, according to court documents. Judge Joseph Goodwin declared a mistrial at 2:15 p.m. today, according to the documents, during the 2nd day of the trial.
Vascular surgical device maker CryoLife announced a regulatory green light today with the FDA's pre-market approval of its Sologrip laser fiber optic delivery system. Sologrip is a disposable handset designed to be used during surgery to support a relatively new procedure called transmyocardial revascularization approved by the FDA to treat difficult heart conditions.
While the use of ultrasound to identify tumors during kidney cancer surgery is gaining acceptance, a research team at Henry Ford Hospital has successfully taken it a step further by showing an added benefit when the procedure is done robotically.
Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced today that its ANCHOR post-market registry enrollment has surpassed its key milestone of 250 patients.
Halt Medical Announces New CPT® Code From the American Medical Association for RF Ablation of Uterine FibroidsJuly 10, 2013 3:00 am | by PR Newswire | News | Comments
Halt Medical is very pleased to announce that the American Medical Association (AMA) Current Procedure Terminology (CPT) Panel has established a new CPT® code specifically for Radiofrequency (RF) Ablation of Uterine Fibroids. CPT codes are used by medical practitioners; including physicians, hospitals, and other healthcare providers to report healthcare services to insurers for the purpose of reimbursement.
PRO-DEX, INC. (Nasdaq: PDEX), a leading medical device developer and manufacturer of world-class powered surgical devices, has partnered with UC Irvine's The Henry Samueli School of Engineering to offer graduating seniors the opportunity to work alongside industry veterans in the design and manufacture of next-generation medical devices.
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that on July 5, 2013 it acquired the assets of Clinical Instruments International, Inc. for $1.1mm, or 1.7X 2012 sales. Clinical Instruments is based in Southbridge, MA and manufactures carotid shunts and embolectomy catheters.
Aesculap Implant Systems announced today the availability of the new Quintex Anterior Cervical Plating System, today’s most versatile system for use in ACDF procedures at multiple levels from C2-T1. Quintex was designed to address all plating ideologies and offers construct options ranging from fully rigid to dynamic, including the new Semidynamic™ option, unique to Aesculap Implant Systems’.
Intuitive Surgical took a nearly 12% hit in after-hours trading today after the medical device company said it expects to miss its 2nd-quarter sales forecast. The Sunnyvale, Calif.-based robotic surgery company said it expects to post sales of roughly $575 million, up 7.3% from the 2nd quarter of 2012 but well shy of analysts' $630 million expectations.
Michael Feiz, M.D., F.A.C.S believes that it's becoming clear that the prevention of cancer is another major benefit of healthy, long-term weight loss that can be fostered by such bariatric procedures as the sleeve gastrectomy and the Lap Band. Obese people are used to hearing warnings regarding heart disease, high blood pressure, diabetes, and stroke; however, the link between obesity and cancer is often left out of the discussion.
Dr. Jie Zheng and Dr. Robert Weiss are among the most recent to contribute to the growing research of hydrogels, the gelatinous substance that, because of its toughness and plasticity, has several biomedical applications, including cartilage repair, implants for minimally invasive surgery and drug delivery.
Early-stage device company Dallen Medical announced a 1st-in-man study of its Compressyn band, a breast-plate wire closure device designed to help stabilize patients after open heart surgery. After the sternum is cracked during open-heart surgery, patients require specialized wires to hold the cavity together.
Life Care Medical Devices Signs Exclusive Agreement with M.E.D. Surgical for the Distribution in Ireland of its Proprietary Keyhole Cup@ Laparoscopic Access DeviceJuly 8, 2013 8:45 am | by The Associated Press | News | Comments
Life Care Medical Devices Ltd., (OTC BB: LCMD), a development stage medical device company today announced that Life Care Medical Devices, Ltd, Ireland signed an exclusive agreement with M.E.D. Surgical, a subsidiary of Sisk Healthcare for the distribution of the Company's Keyhole Cup@ ...
North Carolina medical device maker Baxano Surgical Inc. (NSDQ:BAXS) agreed to pay $6 million to close a Justice Dept. probe initiated nearly 2 years ago. The definitive settlement consummates a tentative agreement the spinal device company forged with federal regulators in December 2012, according to a Baxano Surgical statement.
Medtronic (NYSE:MDT) prevailed in an antitrust lawsuit filed over a bone mill made by Lenox MacLaren Surgical, with a federal judge ruling that Lenox misrepresented the size of the bone mill market and failed to adequately market its own device.
Blaze Biosciences is more than halfway to a targeted $15 million in a Series B round to fund its Tumor Paint, a surgical tool that visually distinguishes solid tumor cells from healthy cells. Founded in 2010, the Seattle, Wash.-based Blaze Biosciences has roped in about $8.1 million since opening the round in June.